Determinants of Neutral Antagonism and Inverse Agonism in the β2-Adrenergic Receptor

被引:1
|
作者
Calderon, Jacqueline C. [1 ]
Ibrahim, Passainte [2 ]
Gobbo, Dorothea [3 ,4 ]
Gervasio, Francesco Luigi [3 ,4 ,5 ,6 ]
Clark, Timothy [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nuernberg, Comp Chem Ctr, Dept Chem & Pharm, D-91052 Erlangen, Germany
[2] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, D-04107 Leipzig, Germany
[3] Univ Geneva, Pharmaceut Sci, CH-1206 Geneva, Switzerland
[4] Inst Pharmaceut Sci Western Switzerland, CH-1206 Geneva, Switzerland
[5] UCL, Chem Dept, London WC1H 0AJ, England
[6] Swiss Bioinformat Inst, Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
PROTEIN-COUPLED RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; ENERGY LANDSCAPES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND EFFICACY; GS-PROTEIN; ACTIVATION; DYNAMICS; BINDING;
D O I
10.1021/acs.jcim.3c01763
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Free-energy profiles for the activation/deactivation of the beta(2)-adrenergic receptor (ADRB2) with neutral antagonist and inverse agonist ligands have been determined with well-tempered multiple-walker (MW) metadynamics simulations. The inverse agonists carazolol and ICI118551 clearly favor single inactive conformational minima in both the binary and ternary ligand-receptor-G-protein complexes, in accord with the inverse-agonist activity of the ligands. The behavior of neutral antagonists is more complex, as they seem also to affect the recruitment of the G-protein. The results are analyzed in terms of the conformational states of the well-known microswitches that have been proposed as indicators of receptor activity.
引用
收藏
页码:2045 / 2057
页数:13
相关论文
共 50 条
  • [21] Activation mechanism of the β2-adrenergic receptor
    Dror, Ron O.
    Arlow, Daniel H.
    Maragakis, Paul
    Mildorf, Thomas J.
    Pan, Albert C.
    Xu, Huafeng
    Borhani, David W.
    Shaw, David E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (46) : 18684 - 18689
  • [22] α2-adrenergic receptor signalling in hypertension
    Kanagy, NL
    CLINICAL SCIENCE, 2005, 109 (05) : 431 - 437
  • [23] CRYSTAL STRUCTURES OF THE β2-ADRENERGIC RECEPTOR
    Weis, William I.
    Rosenbaum, Daniel M.
    Rasmussen, Soren G. F.
    Choi, Hee-Jung
    Thian, Foon Sun
    Kobilka, Tong Sun
    Yao, Xiao-Jie
    Day, Peter W.
    Parnot, Charles
    Fung, Juan J.
    Ratnala, Venkata R. P.
    Kobilka, Brian K.
    Cherezov, Vadim
    Hanson, Michael A.
    Kuhn, Peter
    Stevens, Raymond C.
    Edwards, Patricia C.
    Schertler, Gebhard F. X.
    Burghammer, Manfred
    Sanishvili, Ruslan
    Fischetti, Robert F.
    Masood, Asna
    Rohrer, Daniel K.
    FROM MOLECULES TO MEDICINES: STRUCTURE OF BIOLOGICAL MACROMOLECULES AND ITS RELEVANCE IN COMBATING NEW DISEASES AND BIOTERRORISM, 2009, : 217 - 230
  • [24] Pharmacogenetics of the β2-adrenergic receptor gene
    Ortega, Victor E.
    Hawkins, Gregory A.
    Peters, Stephen P.
    Bleecker, Eugene R.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2007, 27 (04) : 665 - +
  • [25] Epigenetics Of The β2-Adrenergic Receptor Gene
    Ortega, V. E.
    Liggett, S. B.
    Pascual, R.
    Diallo, A.
    Moore, W. C.
    Meyers, D.
    Bleecker, E. R.
    Hawkins, G. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [26] Polymorphisms of the β2-adrenergic receptor.
    Liggett, SB
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07): : 536 - 537
  • [27] scFv single chain antibody variable fragment as inverse agonist of the β2-adrenergic receptor
    Peter, JC
    Eftekhari, P
    Billiald, P
    Wallukat, G
    Hoebeke, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) : 36740 - 36747
  • [28] Role of DNA methylation during recovery from spinal cord injury with and without β2-adrenergic receptor agonism
    Scholpa, Natalie E.
    EXPERIMENTAL NEUROLOGY, 2023, 368
  • [29] β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression
    Lavine, Jeremy A.
    Farnoodian, Mitra
    Wang, Shoujian
    Darjatmoko, Soesiawati R.
    Wright, Lynda S.
    Gamm, David M.
    Ip, Michael S.
    Sorenson, Christine M.
    Sheibani, Nader
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (01) : 299 - 308
  • [30] Assay-Dependent Inverse Agonism at the A3 Adenosine Receptor: When Neutral Is Not Neutral
    Pottie, Eline
    Suresh, R. Rama
    Jacobson, Kenneth A.
    Stove, Christophe P.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 6 (09) : 1266 - 1274